Gunderson Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8M Buy
+9,821
New +$10M 3.18% 13
2026
Q1
Sell
-8,749
Closed -$9.4M 58
2025
Q4
$9.4M Buy
8,749
+703
+9% +$672K 4.24% 6
2025
Q3
$6.14M Buy
8,046
+5,343
+198% +$3.98M 2.26% 20
2025
Q2
$2.11M Buy
2,703
+2,448
+960% +$1.9M 0.88% 35
2025
Q1
$211K Sell
255
-12,058
-98% -$10M 0.14% 27
2024
Q4
$9.51M Sell
12,313
-10,184
-45% -$8.43M 4.67% 8
2024
Q3
$19.9M Buy
22,497
+223
+1% +$200K 8.44% 1
2024
Q2
$20.2M Buy
22,274
+2,369
+12% +$1.9M 8.66% 1
2024
Q1
$15.5M Buy
19,905
+1,247
+7% +$887K 7.19% 2
2023
Q4
$10.9M Buy
18,658
+7,327
+65% +$4.28M 6.21% 1
2023
Q3
$6.09M Buy
+11,331
New +$5.84M 4.14% 10
2023
Q1
Sell
-18,297
Closed -$6.69M 49
2022
Q4
$6.69M Buy
+18,297
New +$6.49M 12.22% 3
2019
Q2
Sell
-1,871
Closed -$243K 66
2019
Q1
$243K Buy
1,871
+8
+0.4% +$973 0.21% 59
2018
Q4
$216K Buy
+1,863
New +$208K 0.94% 10

Other funds holding LLY

Gunderson Capital Management's LLY Position: Q2 2026 in Review

Gunderson Capital Management opened a new position in Eli Lilly (LLY) in Q2 2026: 9,821 shares worth $11.8M. The stake represents 3.18% of the portfolio and ranks #13 among its holdings. This is a return to the name: Gunderson Capital Management previously reported a position in LLY as recently as Q4 2025.

Gunderson Capital Management first reported a position in LLY in Q4 2018 and has held it in 14 quarters since. The position peaked at $20.2M in Q2 2024. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Gunderson Capital Management held 9,821 shares of Eli Lilly worth $11.8M as of Q2 2026.
  • Eli Lilly was a new Gunderson Capital Management position in Q2 2026.
  • Eli Lilly made up 3.18% of Gunderson Capital Management's portfolio in Q2 2026, its #13 holding.
  • Gunderson Capital Management first reported a position in Eli Lilly in Q4 2018 and has held it in 14 quarters since.
  • Gunderson Capital Management's Eli Lilly position peaked at $20.2M in Q2 2024.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Gunderson Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.